EUVIMEDEUVIMED entdecken
Crossref

Discovery and evaluation of biphenyl derivatives of 2‐iminobenzimidazoles as prototype dual PTP1B inhibitors and AMPK activators with in vivo antidiabetic activity

Denis A Babkov, Olga N Zhukovskaya, Anastasia A Brigadirova, Diana R Prilepskaya, Alexandra A Kolodina, Abbas Haider S Abbas iD, Anatolii S Morkovnik, M Elizabeth Sobhia, Ketan Ghosh, Alexander A Spasov

Chemical Biology & Drug Design · 2023

DOI: 10.1111/cbdd.14198 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Chemical Biology & Drug Design, 2023. Verfasst von Denis A Babkov und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology & Bioinformatics, Volgograd State Medical University, Volgograd, Russia. Hauptthemen laut MEDLINE: Hypoglycemic Agents, Diabetes Mellitus, Type 2. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 51 Literaturangaben. Gefördert von: Ministry of Education and Science of the Russian Federation, Russian Science Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This work describes the synthesis of series hydrobromides of N ‐(4‐biphenyl)methyl– N ′‐dialkylaminoethyl‐2‐iminobenzimidazoles, which, due to the presence of two privileged structural fragments (benzimidazole and biphenyl moieties), can be considered as bi‐privileged structures. Compound 7a proved to activate AMP‐activated kinase (AMPK) and simultaneously inhibit protein tyrosine phosphatase 1B (PTP1B) with similar potency. This renders it an interesting prototype of potential antidiabetic agents with a dual‐target mechanism of action. Using prove of concept in vivo study, we show that dual‐targeting compound 7a has a disease‐modifying effect in a rat model of type 2 diabetes mellitus via improving insulin sensitivity and lipid metabolism.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hypoglycemic AgentsDiabetes Mellitus, Type 2RatsAnimalsAMP-Activated Protein KinasesBiphenyl CompoundsProtein Tyrosine Phosphatase, Non-Receptor Type 1Enzyme Inhibitors

Stichwörter der Autor:innen

AMPKPTP1Bdiabetes mellitusobesity

Substanzen

Hypoglycemic AgentsAMP-Activated Protein KinasesBiphenyl CompoundsProtein Tyrosine Phosphatase, Non-Receptor Type 1Enzyme Inhibitorsbiphenyl

Autor:innen und Institutionen

  • Department of Pharmacology & Bioinformatics, Volgograd State Medical University, Volgograd, Russia.
  • Scientific Center for Innovative Drugs, Volgograd State Medical University, Volgograd, Russia.
  • Institute of Physical and Organic Chemistry, Southern Federal University, Rostov-on-Don, Russia.
  • Department of Pharmacoinformatics, National Institute of Pharmaceutical Education and Research (NIPER), SAS Nagar, India.

ORCID-Profile: Abbas Haider S Abbas

Förderung

  • Ministry of Education and Science of the Russian Federation
  • Russian Science Foundation

Zitieren

APA

Babkov, D. A., Zhukovskaya, O. N., Brigadirova, A. A., Prilepskaya, D. R., Kolodina, A. A., Abbas, A. H. S., Morkovnik, A. S., Sobhia, M. E., Ghosh, K., & Spasov, A. A. (2023). Discovery and evaluation of biphenyl derivatives of 2‐iminobenzimidazoles as prototype dual PTP1B inhibitors and AMPK activators with in vivo antidiabetic activity. Chemical Biology & Drug Design. https://doi.org/10.1111/cbdd.14198

Vancouver

Babkov DA, Zhukovskaya ON, Brigadirova AA, Prilepskaya DR, Kolodina AA, Abbas AHS, et al. Discovery and evaluation of biphenyl derivatives of 2‐iminobenzimidazoles as prototype dual PTP1B inhibitors and AMPK activators with in vivo antidiabetic activity. Chemical Biology & Drug Design. 2023. doi:10.1111/cbdd.14198

BibTeX
@article{Babkov2023,
  author = {Babkov, Denis A and Zhukovskaya, Olga N and Brigadirova, Anastasia A and Prilepskaya, Diana R and Kolodina, Alexandra A and Abbas, Abbas Haider S and Morkovnik, Anatolii S and Sobhia, M Elizabeth and Ghosh, Ketan and Spasov, Alexander A},
  title = {Discovery and evaluation of biphenyl derivatives of 2‐iminobenzimidazoles as prototype dual PTP1B inhibitors and AMPK activators with in vivo antidiabetic activity},
  journal = {Chemical Biology & Drug Design},
  year = {2023},
  doi = {10.1111/cbdd.14198}
}
Kostenlos starten →